开发临床药代动力学研究中生物样品物流的通用实验室手册

R. Abbott, Rebecca Sleigh, J. Long, C. Ekstrom, B. Matthes, José Groenboom-Nieuwenhuijzen
{"title":"开发临床药代动力学研究中生物样品物流的通用实验室手册","authors":"R. Abbott, Rebecca Sleigh, J. Long, C. Ekstrom, B. Matthes, José Groenboom-Nieuwenhuijzen","doi":"10.4155/CLI.15.42","DOIUrl":null,"url":null,"abstract":"2015 The European Bioanalysis Forum (EBF) has been organizing ‘Topic Teams’ on issues of importance to the bioanalytical community for several years [1]. Many of these teams focus on internal bioanalytical issues of importance to bioanalysts such as technological innovation, regulatory questions and novel assay validation approaches [2]. However, there is an increasing recognition that we do need to pay more attention to external factors such as interactions and communication regarding clinical, toxicology and project team participation [3]. Topic Team 12, a virtual team of ten EBF member companies and meeting every 2 to 3 weeks by teleconference, focused on topics of interest associated with clinical trial support. Following a member survey and extended team discussion it was felt that the generation of a generic laboratory manual for use in clinical pharmacokinetic studies would offer a potential solution to the common problems created by poor logistical sample management and communication in single and multicentre trials [4]. Such a document would create a single platform to which clinical sites, central laboratories and bioanalytical groups could all relate. The benefits could be significant since a harmonized document should stimulate a consistent way of working and would be a first step in the elimination of many current issues.","PeriodicalId":10369,"journal":{"name":"Clinical investigation","volume":"5 1","pages":"741-744"},"PeriodicalIF":0.0000,"publicationDate":"2015-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Development of a generic laboratory manual for biological sample logistics in clinical pharmacokinetic studies\",\"authors\":\"R. Abbott, Rebecca Sleigh, J. Long, C. Ekstrom, B. Matthes, José Groenboom-Nieuwenhuijzen\",\"doi\":\"10.4155/CLI.15.42\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"2015 The European Bioanalysis Forum (EBF) has been organizing ‘Topic Teams’ on issues of importance to the bioanalytical community for several years [1]. Many of these teams focus on internal bioanalytical issues of importance to bioanalysts such as technological innovation, regulatory questions and novel assay validation approaches [2]. However, there is an increasing recognition that we do need to pay more attention to external factors such as interactions and communication regarding clinical, toxicology and project team participation [3]. Topic Team 12, a virtual team of ten EBF member companies and meeting every 2 to 3 weeks by teleconference, focused on topics of interest associated with clinical trial support. Following a member survey and extended team discussion it was felt that the generation of a generic laboratory manual for use in clinical pharmacokinetic studies would offer a potential solution to the common problems created by poor logistical sample management and communication in single and multicentre trials [4]. Such a document would create a single platform to which clinical sites, central laboratories and bioanalytical groups could all relate. The benefits could be significant since a harmonized document should stimulate a consistent way of working and would be a first step in the elimination of many current issues.\",\"PeriodicalId\":10369,\"journal\":{\"name\":\"Clinical investigation\",\"volume\":\"5 1\",\"pages\":\"741-744\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-10-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical investigation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4155/CLI.15.42\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical investigation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4155/CLI.15.42","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

欧洲生物分析论坛(EBF)几年来一直在组织“主题团队”讨论生物分析界的重要问题[1]。这些团队中的许多人专注于对生物分析学家至关重要的内部生物分析问题,如技术创新、监管问题和新的分析验证方法[2]。然而,越来越多的人认识到,我们确实需要更多地关注外部因素,如临床、毒理学和项目团队参与方面的互动和沟通[3]。主题小组12,一个由10个EBF成员公司组成的虚拟团队,每2到3周通过电话会议召开一次会议,重点讨论与临床试验支持相关的主题。经过成员调查和扩展的团队讨论,人们认为,用于临床药代动力学研究的通用实验室手册的生成将为单中心和多中心试验中由于缺乏后勤样本管理和沟通而产生的常见问题提供潜在的解决方案[4]。这样一份文件将创建一个单一的平台,临床站点、中心实验室和生物分析小组都可以与之联系。这样做的好处可能是巨大的,因为一份统一的文件应该促进一种一致的工作方式,并将是消除许多当前问题的第一步。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Development of a generic laboratory manual for biological sample logistics in clinical pharmacokinetic studies
2015 The European Bioanalysis Forum (EBF) has been organizing ‘Topic Teams’ on issues of importance to the bioanalytical community for several years [1]. Many of these teams focus on internal bioanalytical issues of importance to bioanalysts such as technological innovation, regulatory questions and novel assay validation approaches [2]. However, there is an increasing recognition that we do need to pay more attention to external factors such as interactions and communication regarding clinical, toxicology and project team participation [3]. Topic Team 12, a virtual team of ten EBF member companies and meeting every 2 to 3 weeks by teleconference, focused on topics of interest associated with clinical trial support. Following a member survey and extended team discussion it was felt that the generation of a generic laboratory manual for use in clinical pharmacokinetic studies would offer a potential solution to the common problems created by poor logistical sample management and communication in single and multicentre trials [4]. Such a document would create a single platform to which clinical sites, central laboratories and bioanalytical groups could all relate. The benefits could be significant since a harmonized document should stimulate a consistent way of working and would be a first step in the elimination of many current issues.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信